Wedbush Securities Inc Ovid Therapeutics Inc. Transaction History

Wedbush Securities Inc

  • $2.7 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$2.28 - $6.84 $24,851 - $74,556
-10,900 Closed
0 $0
Q3 2020

Oct 20, 2020
BUY
$5.39 - $8.24 $58,751 - $89,816
10,900 New
10,900 $63,000
Q2 2020

Jul 16, 2020
SELL
$2.67 - $7.91 $77,670 - $230,101
-29,090 Closed
0 $0
Q1 2020

Apr 17, 2020
BUY
$2.03 - $4.35 $59,052 - $126,541
29,090 New
29,090 $87,000

Others Institutions Holding OVID

# of Institutions
75
Shares Held
39M
Call Options Held
37.4K
Put Options Held
500
View Full List

About Ovid Therapeutics Inc.

OVID Quotes by TradingView
  • Ticker OVID
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,419,400
  • Market Cap $67.6M
  • Description
  • Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...
More about OVID
Track This Portfolio

Track Wedbush Securities Inc Portfolio

Follow Wedbush Securities Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wedbush Securities Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email